Boehringer Ingelheim appoints Harsha Deshmukh to its Board of Managing Directors
Ingelheim: Boehringer Ingelheim has announced that the Shareholders' Committee has appointed Harsha Deshmukh to the Board of Managing Directors. effective 1 February 2026.
Harsha Deshmukh will lead the IT and Global Business Services functions focusing on digital transformation and driving the further development of business services at the company. IT and Global Business Services, which so far were part of the Group Functions Division, will be set up as a separate Board Division.
Commenting on the appointment, Hubertus von Baumbach, Chairman of the Boehringer Shareholders’ Committee said, “We warmly welcome Harsha Deshmukh. With his extensive experience in fostering innovation, he will help drive our journey of transformation – a transformation in the interest of patients. We know that in this process of continuous improvement we can rely on the proven skills, the contributions and the high commitment of each individual in our organization.”
Chairman of the Board of Managing Directors Shashank Deshpande added, “I am excited to welcome Harsha to Boehringer Ingelheim. His appointment strengthens our capabilities in the important segments of IT and services, two areas that are critical elements to underpin our future growth.”
Harsha Deshmukh will join Boehringer Ingelheim from Infineon Technologies AG in Munich, where he most recently was Executive Vice President & Chief Information Officer. He holds degrees in Electronics, Human Resources and Global Management from the University of Mumbai, Babson College and INSEAD.
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health.
Read also: Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.